These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 30181416)

  • 1. NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.
    Flaig TW; Spiess PE; Agarwal N; Bangs R; Boorjian SA; Buyyounouski MK; Downs TM; Efstathiou JA; Friedlander T; Greenberg RE; Guru KA; Hahn N; Herr HW; Hoimes C; Inman BA; Jimbo M; Kader AK; Lele SM; Meeks JJ; Michalski J; Montgomery JS; Pagliaro LC; Pal SK; Patterson A; Petrylak DP; Plimack ER; Pohar KS; Porter MP; Preston MA; Sexton WJ; Siefker-Radtke AO; Tward J; Wile G; Johnson-Chilla A; Dwyer MA; Gurski LA
    J Natl Compr Canc Netw; 2018 Sep; 16(9):1041-1053. PubMed ID: 30181416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International consensus for advanced bladder cancer: an opportunity between the lines.
    Murthy V
    Ann Oncol; 2019 Nov; 30(11):1688-1690. PubMed ID: 31750878
    [No Abstract]   [Full Text] [Related]  

  • 3. Bladder cancer.
    Clark PE; Agarwal N; Biagioli MC; Eisenberger MA; Greenberg RE; Herr HW; Inman BA; Kuban DA; Kuzel TM; Lele SM; Michalski J; Pagliaro LC; Pal SK; Patterson A; Plimack ER; Pohar KS; Porter MP; Richie JP; Sexton WJ; Shipley WU; Small EJ; Spiess PE; Trump DL; Wile G; Wilson TG; Dwyer M; Ho M;
    J Natl Compr Canc Netw; 2013 Apr; 11(4):446-75. PubMed ID: 23584347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: which patients benefit?
    Niegisch G; Lorch A; Droller MJ; Lavery HJ; Stensland KD; Albers P
    Eur Urol; 2013 Sep; 64(3):355-7. PubMed ID: 23773558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Casali PG; Abecassis N; Aro HT; Bauer S; Biagini R; Bielack S; Bonvalot S; Boukovinas I; Bovee JVMG; Brodowicz T; Broto JM; Buonadonna A; De Álava E; Dei Tos AP; Del Muro XG; Dileo P; Eriksson M; Fedenko A; Ferraresi V; Ferrari A; Ferrari S; Frezza AM; Gasperoni S; Gelderblom H; Gil T; Grignani G; Gronchi A; Haas RL; Hassan B; Hohenberger P; Issels R; Joensuu H; Jones RL; Judson I; Jutte P; Kaal S; Kasper B; Kopeckova K; Krákorová DA; Le Cesne A; Lugowska I; Merimsky O; Montemurro M; Pantaleo MA; Piana R; Picci P; Piperno-Neumann S; Pousa AL; Reichardt P; Robinson MH; Rutkowski P; Safwat AA; Schöffski P; Sleijfer S; Stacchiotti S; Sundby Hall K; Unk M; Van Coevorden F; van der Graaf WTA; Whelan J; Wardelmann E; Zaikova O; Blay JY;
    Ann Oncol; 2018 Oct; 29(Suppl 4):iv51-iv67. PubMed ID: 29846498
    [No Abstract]   [Full Text] [Related]  

  • 6. Can bladder preservation therapy come to the center stage?
    Inamoto T; Ibuki N; Komura K; Juri H; Yamamoto K; Yamamoto K; Fujita K; Nonomura N; Narumi Y; Azuma H
    Int J Urol; 2018 Feb; 25(2):134-140. PubMed ID: 29171098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024.
    Flaig TW; Spiess PE; Abern M; Agarwal N; Bangs R; Buyyounouski MK; Chan K; Chang SS; Chang P; Friedlander T; Greenberg RE; Guru KA; Herr HW; Hoffman-Censits J; Kaimakliotis H; Kishan AU; Kundu S; Lele SM; Mamtani R; Mian OY; Michalski J; Montgomery JS; Parikh M; Patterson A; Peyton C; Plimack ER; Preston MA; Richards K; Sexton WJ; Siefker-Radtke AO; Stewart T; Sundi D; Tollefson M; Tward J; Wright JL; Cassara CJ; Gurski LA
    J Natl Compr Canc Netw; 2024 May; 22(4):216-225. PubMed ID: 38754471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer.
    Kulkarni GS; Hakenberg OW; Gschwend JE; Thalmann G; Kassouf W; Kamat A; Zlotta A
    Eur Urol; 2010 Jan; 57(1):60-70. PubMed ID: 19740595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.
    Spiess PE; Agarwal N; Bangs R; Boorjian SA; Buyyounouski MK; Clark PE; Downs TM; Efstathiou JA; Flaig TW; Friedlander T; Greenberg RE; Guru KA; Hahn N; Herr HW; Hoimes C; Inman BA; Jimbo M; Kader AK; Lele SM; Meeks JJ; Michalski J; Montgomery JS; Pagliaro LC; Pal SK; Patterson A; Plimack ER; Pohar KS; Porter MP; Preston MA; Sexton WJ; Siefker-Radtke AO; Sonpavde G; Tward J; Wile G; Dwyer MA; Gurski LA
    J Natl Compr Canc Netw; 2017 Oct; 15(10):1240-1267. PubMed ID: 28982750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Strategy for Newly Diagnosed T1 High-grade Bladder Urothelial Carcinoma: New Insights and Updated Recommendations.
    Klaassen Z; Kamat AM; Kassouf W; Gontero P; Villavicencio H; Bellmunt J; van Rhijn BWG; Hartmann A; Catto JWF; Kulkarni GS
    Eur Urol; 2018 Nov; 74(5):597-608. PubMed ID: 30017405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Casali PG; Bielack S; Abecassis N; Aro HT; Bauer S; Biagini R; Bonvalot S; Boukovinas I; Bovee JVMG; Brennan B; Brodowicz T; Broto JM; Brugières L; Buonadonna A; De Álava E; Dei Tos AP; Del Muro XG; Dileo P; Dhooge C; Eriksson M; Fagioli F; Fedenko A; Ferraresi V; Ferrari A; Ferrari S; Frezza AM; Gaspar N; Gasperoni S; Gelderblom H; Gil T; Grignani G; Gronchi A; Haas RL; Hassan B; Hecker-Nolting S; Hohenberger P; Issels R; Joensuu H; Jones RL; Judson I; Jutte P; Kaal S; Kager L; Kasper B; Kopeckova K; Krákorová DA; Ladenstein R; Le Cesne A; Lugowska I; Merimsky O; Montemurro M; Morland B; Pantaleo MA; Piana R; Picci P; Piperno-Neumann S; Pousa AL; Reichardt P; Robinson MH; Rutkowski P; Safwat AA; Schöffski P; Sleijfer S; Stacchiotti S; Strauss SJ; Sundby Hall K; Unk M; Van Coevorden F; van der Graaf WTA; Whelan J; Wardelmann E; Zaikova O; Blay JY;
    Ann Oncol; 2018 Oct; 29(Suppl 4):iv79-iv95. PubMed ID: 30285218
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant Chemotherapy Is More Suitable Than Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer Patients Treated With Radical Chemoradiotherapy.
    Joseph N; Choudhury A
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):614-6. PubMed ID: 27681756
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of muscle-invasive bladder cancer: A systematic review.
    Chou R; Selph SS; Buckley DI; Gustafson KS; Griffin JC; Grusing SE; Gore JL
    Cancer; 2016 Mar; 122(6):842-51. PubMed ID: 26773572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder cancer. Clinical guidelines in oncology.
    Montie JE; Abrahams NA; Bahnson RR; Eisenberger MA; El-Galley R; Herr HW; Hudes GR; Kuzel TM; Lange PH; Patterson A; Pollack A; Richie JP; Sexton WJ; Shipley WU; Small EJ; Trump DL; Walther PJ; Wilson TG;
    J Natl Compr Canc Netw; 2006 Nov; 4(10):984-1014. PubMed ID: 17112448
    [No Abstract]   [Full Text] [Related]  

  • 15. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
    Benson AB; Venook AP; Al-Hawary MM; Cederquist L; Chen YJ; Ciombor KK; Cohen S; Cooper HS; Deming D; Engstrom PF; Grem JL; Grothey A; Hochster HS; Hoffe S; Hunt S; Kamel A; Kirilcuk N; Krishnamurthi S; Messersmith WA; Meyerhardt J; Mulcahy MF; Murphy JD; Nurkin S; Saltz L; Sharma S; Shibata D; Skibber JM; Sofocleous CT; Stoffel EM; Stotsky-Himelfarb E; Willett CG; Wuthrick E; Gregory KM; Gurski L; Freedman-Cass DA
    J Natl Compr Canc Netw; 2018 Jul; 16(7):874-901. PubMed ID: 30006429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving Treatment Paradigm in the Treatment of Locally Advanced Rectal Cancer.
    Smith CA; Kachnic LA
    J Natl Compr Canc Netw; 2018 Jul; 16(7):909-915. PubMed ID: 30006431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SEOM clinical guidelines for the treatment of invasive bladder cancer.
    Morales R; Font A; Carles J; Isla D
    Clin Transl Oncol; 2011 Aug; 13(8):552-9. PubMed ID: 21821489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practice pattern of non-muscle invasive bladder cancer in Japan, Korea and Taiwan: A Web-based survey.
    Choo SH; Nishiyama H; Kitamura H; Chen CH; Pu YS; Lee HL; Jeong BC; Kim SI
    Int J Urol; 2019 Dec; 26(12):1121-1127. PubMed ID: 31512280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update.
    Hall MC; Chang SS; Dalbagni G; Pruthi RS; Seigne JD; Skinner EC; Wolf JS; Schellhammer PF
    J Urol; 2007 Dec; 178(6):2314-30. PubMed ID: 17993339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.